Search
for

    Sort by

    Research 751–780 of 1000+

    1. Oral tofacitinib for recalcitrant lichen planus pigmentosus: A hospital-based retrospective study Journal of General-Procedural Dermatology & Venereology Indonesia · 2026
    2. P166 Real-world efficacy and tolerability of oral dutasteride combined with oral minoxidil for male androgenetic alopecia: a retrospective cohort study British Journal of Dermatology · 2026
    3. Frontal Fibrosing Alopecia Successfully Treated with Intralesional Betamethasone and Oral Hydroxychloroquine: A Case Report Scholars Journal of Medical Case Reports · 2026
    4. No Increased Cardiovascular Hazard with Oral 5-Alpha-Reductase Inhibitors in Treatment of Androgenetic Alopecia: A TriNetX Retrospective Cohort Study Journal of the American Academy of Dermatology · 2026
    5. Comparative Study of effectiveness of low dose Oral Minoxidil vs Topical Minoxidil (5%) in Male Androgenetic Alopecia. Journal of Pakistan Association of Dermatologists · 2026
    6. O IMPACTO DO USO PERIOPERATÓRIO DA DUTASTERIDA (ORAL E MESOTERAPIA) NOS RESULTADOS ESTÉTICOS DO TRANSPLANTE CAPILAR: UMA REVISÃO DE LITERATURA Revista Ibero-Americana de Humanidades, Ciências e Educação · 2026
    7. Placebo effect of topical and oral treatments for androgenetic alopecia A systematic review and meta-analysis Mendeley Data · 2026
    8. Placebo effect of topical and oral treatments for androgenetic alopecia A systematic review and meta-analysis Mendeley Data · 2026
    9. Use of oral Janus kinase inhibitors for the treatment of severe alopecia areata: narrative review and real-world experience Immunological Medicine · 2026
    10. Placebo effect of topical and oral treatments for androgenetic alopecia A systematic review and meta-analysis Mendeley Data · 2026
    11. Placebo effect of topical and oral treatments for androgenetic alopecia A systematic review and meta-analysis Mendeley Data · 2026
    12. Rethinking Oral Minoxidil: Distinguishing the Hair-Growth Window from the Cardiovascular Threshold Journal of the American Academy of Dermatology · 2026
    13. Cardiovascular Safety Signals of Oral Versus Topical Minoxidil in FAERS: A Disproportionality Analysis (Analytic Cohort 2012–2025) Life · 2026
    14. ORAL AND TOPICAL FINASTERIDE IN THE TREATMENT OF MALE ANDROGENETIC ALOPECIA – NARRATIVE REVIEW Archiv Euromedica · 2026
    15. Preclinical efficacy and safety evaluation of a topical mesenchymal stem cell derived conditioned media gel for oral mucositis management Scientific Reports · 2026
    16. Oral Tofacitinib for Refractory Lichen Planus Pigmentosus Coexisting with Frontal Fibrosing Alopecia Indian Dermatology Online Journal · 2026
    17. Comparative efficacy of oral dutasteride and low-, medium-, and high-dose oral minoxidil: a six-month prospective trichoscopic and clinical study Frontiers in Medicine · 2026
    18. Expanding the therapeutic landscape of minoxidil for androgenetic alopecia: topical, oral and sublingual formulations Frontiers in Pharmacology · 2026
    19. Oral finasteride use and sexual adverse events: signal detection from disproportionality analyses of data from the United States Food and Drug Administration Adverse Event Reporting System Journal of Dermatological Treatment · 2026
    20. O-21 FROM ORAL LEVOTHYROXINE RESISTANCE TO INTRAVENOUS LEVOTHYROXINE HYPERSENSITIVITY: A CHALLENGING PRIMARY HYPOTHYROIDISM CASE JCEM Case Reports · 2026
    21. Randomized controlled trial to compare the efficacy of oral minoxidil 1.25 mg versus 2.5 mg versus topical 5% minoxidil in androgenetic alopecia Dermatologica Sinica · 2026
    22. Comparative Efficacy of Oral and Topical 5-Alpha Reductase Inhibitors in Reducing Dihydrotestosterone levels across Men with Androgenetic Alopecia: A Network Meta-Analysis incorporating Post-Hoc Analyses of Randomized Clinical Trial Data Open Science Framework · 2026
    23. Oral Minoxidil Administration and its Effects on Reproductive, Lipid, and Hematological Profiles in Male Sprague Dawley Rats SSRN Electronic Journal · 2026
    24. Combined Low Dose Oral Minoxidil and Immunomodulator Efficacy and Safety in Alopecia Areata: A Systematic Review International Journal of Dermatology · 2025
    25. When JAK inhibitors are off the table: durable remission of severe alopecia areata with dexamethasone oral mini-pulse and a focused review Journal of Dermatological Treatment · 2025
    26. The Use of Oral Dutasteride, Minoxidil, and Finasteride for Treating Endocrine Therapy-Induced Hair Loss from Breast Cancer Treatment: A Case Series Study JAAD Case Reports · 2025
    27. A rare case of chronic genian fistula with oral mucosal hair follicle inclusion: case report and review of the literature Frontiers in Oral Health · 2025
    28. Oral Minoxidil for Alopecia Treatment: Risks, Benefits, and Recommendations American Journal of Clinical Dermatology · 2025
    29. Effectiveness and Safety of Combined Therapy with Oral Minoxidil, Oral Dutasteride, and Mesotherapy with Dutasteride in Real Clinical Practice 2025
    30. Is the Addition of Oral Biotin to PRP More Beneficial for Treating Male Pattern Hair Loss Compared to PRP Alone? A Randomized Control Trial Journal of Pakistan Association of Dermatologists · 2025